Loading…
This event has ended. Visit the official site or create your own event on Sched.

Science at the US-Africa Leaders Summit, Washington, DC, 12-15 December 2022

ISC and partners will organise a series of side events focussing on the contribution of science to the U.S.-Africa Leaders Summit and its outcomes taking place in Washington on 12-15 December 2022. The US-Africa Summit is intended to demonstrate the United States enduring commitment to Africa and underscore the importance of U.S.-Africa relations and increased cooperation on shared global priorities. White House Announcement

                       The programme is in development, so please monitor it for updates

The Summit will build on shared values to better foster new economic engagement; reinforce the U.S.-Africa commitment to democracy and human rights; mitigate the impact of COVID-19 and future pandemics; work collaboratively to strengthen regional and global health; promote food security; advance peace and security; respond to the climate crisis, and amplify diaspora ties.

ISC will organise a series of events designed to highlight the role and contribution of science to the US-Africa relationship under the heading of Science at the US-Africa Leaders Summit 2022. ISC organised a similar series of meetings during the last US-African Leaders Summit, which took place in 2014. The objectives of the meetings will be to highlight the importance of science in Africa, to foster greater collaboration between African nations and the US, and to increase investment in science for Global Health, Digital Transition, Space, Biological Diversity, Education and Skills, among other areas and to support an enabling policy and regulatory environment for science collaboration to flourish between Africa and the US.
avatar for Emmanuel Balandya

Emmanuel Balandya

Muhimbili University of Health and Allied Sciences (MUHAS)
Director, Postgraduate Studies; PI, SPARCo-Tanzania
Tanzania
Prof. Emmanuel Balandya is a physician-scientist with expertise in biomedical sciences, encompassing Physiology, Haematology, and Immunology. He obtained his Medical Degree at the University of Dar-es-salaam, Tanzania (2005); Doctorate Degree at Dartmouth College, USA (2012), and a postdoctoral
fellowship at Harvard Medical School, USA (2014). Following his return to Tanzania, he researched on
immunity and infections in Sickle Cell Disease (through the NIHFIC/ NHLBI/UCSF Global Health Fellowship) and is currently PI of the NIH/NHLBI-funded U01 HL156853 grant titled Sickle Pan - African Research Consortium (SPARCo)-Tanzania, part of the larger SickleInAfrica Consortium involving Tanzania, Nigeria, Ghana, Mali, Uganda, Zimbabwe, Zambia, and South Africa. He is a co-Investigator in several ongoing health research and education capacity-building projects at MUHAS. He is published and has presented his work on national and international platforms. Prof. Balandya is also a Member of the Organizing Committees for the MUHAS Scientific Conference and National NCD Scientific Conference in Tanzania; is a Director of Postgraduate Studies at MUHAS; Board Member of Young Scientists Tanzania (YST), a nationwide Science
Outreach Programme, and consults with the National Institute for Medical Research (NIMR) and Tanzania Commission for Universities (TCU) on matters related to health research and education. He is a scientific reviewer for the Tanzania Journal of Health Research (TJHR), Allergologia et Immunopathologia, Lancet Haematology, Journal of Community Genetics, and PLOS ONE.